Estrogen monitoring in ovulation induction.
D001201:Ascites / Q000139:chemically induced; D004967:Estrogens / Q000302:isolation & purification / Q000652:urine*; D005260:Female; D006062:Gonadotropins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007247:Infertility, Female / Q000188:drug therapy*; D008722:Methods; D010049:Ovarian Diseases / Q000139:chemically induced; D010060:Ovulation / Q000187:drug effects*; D011247:Pregnancy; D011272:Pregnancy, Multiple; D014310:Triplets; D014427:Twins; D014481:United States; D014486:United States Food and Drug Administration
D004967:Estrogens; D006062:Gonadotropins